Compare ADV & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADV | OVID |
|---|---|---|
| Founded | 1987 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 523.2M | 522.6M |
| IPO Year | 2019 | 2017 |
| Metric | ADV | OVID |
|---|---|---|
| Price | $32.89 | $2.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $45.83 | $4.60 |
| AVG Volume (30 Days) | 108.2K | ★ 1.5M |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.90 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,542,642,000.00 | $7,252,000.00 |
| Revenue This Year | $0.63 | N/A |
| Revenue Next Year | $0.45 | $19.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1181.27 |
| 52 Week Low | $0.49 | $0.84 |
| 52 Week High | $47.45 | $3.11 |
| Indicator | ADV | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 45.19 | 63.71 |
| Support Level | $0.78 | $2.22 |
| Resistance Level | $44.60 | $3.05 |
| Average True Range (ATR) | 3.60 | 0.15 |
| MACD | -0.42 | 0.04 |
| Stochastic Oscillator | 48.66 | 86.67 |
Advantage Solutions Inc provides outsourced sales, marketing, merchandising, sampling, and retailer support services to consumer packaged goods manufacturers and retailers across North America. Its services are designed to support distribution, retail execution, shopper engagement, and private brand development across both physical and digital commerce environments. The company serves various clients across grocery, mass, club, retail pharmacy, convenience, and other channels. It operates through three reportable segments: Branded Services, Experiential Services, and Retailer Services. The majority of the revenue is derived from the Experiential Services segment, which provides in-store and digital sampling programs, demonstrations, and experiential events for manufacturers and retailers.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.